Literature DB >> 24647916

Analysis of the quantitative improvements in resting echocardiographic image sharpness through the use of contrast enhanced echocardiography.

Matthew S Glassy1, Elliott M Groves.   

Abstract

Contrast enhanced echocardiography (CEE) is a technique for the improvement of suboptimal echocardiographic studies. While commonly performed at selected institutions, its value has only been shown qualitatively, and to this point no study has been directed at establishing a quantitative improvement in image quality compared with non-contrast enhanced echocardiography (non-CEE). The purpose of this study was to quantitatively measure the effect of contrast on the quality of images obtained during non-CEE versus CEE. Thirty consecutive patients underwent CEE. In all subjects a non-CEE was obtained prior to administering any contrast, allowing for a direct comparison and an internal control group. Sharpness of the septal, apical and lateral myocardial walls in the apical 4-chamber view was calculated with and without contrast. Three signal intensity levels were obtained for each wall then averaged to compare the images with and without contrast for a statistically significant difference in sharpness. Quantitative analysis showed a significant difference in sharpness between CEE and non-CEE in the left ventricular septal myocardial wall, p < 0.01. A more drastic significant increase in image sharpness was observed between non-CEE and CEE in the apical and lateral left ventricular myocardial walls, both p < 0.000001. CEE significantly increases the sharpness at all left ventricular myocardial walls thus allowing higher quality images with presumably more accurate diagnosis of regional wall motion abnormalities, left ventricular endocardial border detection, left ventricular dimensions, ejection fraction and apical pathology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24647916     DOI: 10.1007/s10554-014-0401-4

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  25 in total

1.  High-resolution breath-hold contrast-enhanced MR angiography of the entire carotid circulation.

Authors:  James C Carr; Jason Ma; Vibhas Desphande; Scott Pereles; Gerhard Laub; J Paul Finn
Journal:  AJR Am J Roentgenol       Date:  2002-03       Impact factor: 3.959

2.  Analysis of regional left ventricular function by cineventriculography, cardiac magnetic resonance imaging, and unenhanced and contrast-enhanced echocardiography: a multicenter comparison of methods.

Authors:  Rainer Hoffmann; Stephan von Bardeleben; Jaroslaw D Kasprzak; Adrian C Borges; Folkert ten Cate; Christian Firschke; Stephane Lafitte; Nidal Al-Saadi; Stefanie Kuntz-Hehner; Georg Horstick; Christian Greis; Marc Engelhardt; Jean Louis Vanoverschelde; Harald Becher
Journal:  J Am Coll Cardiol       Date:  2005-12-15       Impact factor: 24.094

3.  Incidence of adverse events associated with use of perflutren contrast agents for echocardiography.

Authors:  Charles A Herzog
Journal:  JAMA       Date:  2008-05-07       Impact factor: 56.272

4.  Limits of normal left ventricular dimensions in growth and development: analysis of dimensions and variance in the two-dimensional echocardiograms of 268 normal healthy subjects.

Authors:  J D Pearlman; M O Triulzi; M E King; J Newell; A E Weyman
Journal:  J Am Coll Cardiol       Date:  1988-12       Impact factor: 24.094

5.  Peripheral venous contrast echocardiography.

Authors:  J B Seward; A J Tajik; D J Hagler; D G Ritter
Journal:  Am J Cardiol       Date:  1977-02       Impact factor: 2.778

6.  Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective, randomly assigned, blinded study.

Authors:  H L Thomson; A J Basmadjian; A J Rainbird; M Razavi; J F Avierinos; P A Pellikka; K R Bailey; J F Breen; M Enriquez-Sarano
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

Review 7.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

Authors:  Kenneth Dickstein; Alain Cohen-Solal; Gerasimos Filippatos; John J V McMurray; Piotr Ponikowski; Philip Alexander Poole-Wilson; Anna Strömberg; Dirk J van Veldhuisen; Dan Atar; Arno W Hoes; Andre Keren; Alexandre Mebazaa; Markku Nieminen; Silvia Giuliana Priori; Karl Swedberg
Journal:  Eur Heart J       Date:  2008-09-17       Impact factor: 29.983

8.  Determination of left ventricular ejection fraction using intravenous contrast and a semiautomated border detection algorithm.

Authors:  Eric H c Yu; Danny M Skyba; Cairrine E Sloggett; Michal Jamorski; R Mark Iwanochko; Bryan F Dias; Harry Rakowski; Samuel C Siu
Journal:  J Am Soc Echocardiogr       Date:  2003-01       Impact factor: 5.251

9.  Contrast-enhanced anatomic imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus.

Authors:  Jonathan W Weinsaft; Raymond J Kim; Michael Ross; Daniel Krauser; Shant Manoushagian; Troy M LaBounty; Matthew D Cham; James K Min; Kirsten Healy; Yi Wang; Michele Parker; Mary J Roman; Richard B Devereux
Journal:  JACC Cardiovasc Imaging       Date:  2009-08

10.  Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study.

Authors:  Simon Walker; François Girardin; Claire McKenna; Stephen G Ball; Jane Nixon; Sven Plein; John P Greenwood; Mark Sculpher
Journal:  Heart       Date:  2013-04-16       Impact factor: 5.994

View more
  1 in total

Review 1.  Recent technological advancements in cardiac ultrasound imaging.

Authors:  Jaydev K Dave; Maureen E Mc Donald; Praveen Mehrotra; Andrew R Kohut; John R Eisenbrey; Flemming Forsberg
Journal:  Ultrasonics       Date:  2017-11-23       Impact factor: 2.890

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.